Enisa Hasic

538 total citations
8 papers, 424 citations indexed

About

Enisa Hasic is a scholar working on Molecular Biology, Ophthalmology and Immunology. According to data from OpenAlex, Enisa Hasic has authored 8 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Ophthalmology and 2 papers in Immunology. Recurrent topics in Enisa Hasic's work include Retinal Diseases and Treatments (2 papers), Glaucoma and retinal disorders (2 papers) and Retinal Development and Disorders (1 paper). Enisa Hasic is often cited by papers focused on Retinal Diseases and Treatments (2 papers), Glaucoma and retinal disorders (2 papers) and Retinal Development and Disorders (1 paper). Enisa Hasic collaborates with scholars based in Australia. Enisa Hasic's co-authors include Peter Hersey, Austin Edwards, William H. McCarthy, Anne Edwards, Svetlana Cherepanoff, Malcolm MacDonald, Lay Khoon Too, G. W. Milton, Anne Edwards and Alan S. Coates and has published in prestigious journals such as The Lancet, The Journal of Immunology and British Journal of Cancer.

In The Last Decade

Enisa Hasic

8 papers receiving 403 citations

Peers

Enisa Hasic
Comparison fields: 5 of 79
  • Dermatology 153
  • Immunology 151
  • Molecular Biology 90
  • Oncology 72
  • Epidemiology 48
Replace J Wayne Streilein with:
J Wayne Streilein United States
Peter Knuschke Germany
Xun Zeng China
Ruud A.J. Warringa Netherlands
Å. Bengtsson Sweden
Anne Kagey-Sobotka United States
Annabelle Grolleau‐Julius United States
Haruki Mikawa Japan
Erika Méndez-Enríquez Sweden
Yasmin A. Chandrasekher United States
J Wayne Streilein United States View profile →
Citations per field, relative to Enisa Hasic
Enisa Hasic · 1×
Citations per year, relative to Enisa Hasic
Enisa Hasic · 1×

Countries citing papers authored by Enisa Hasic

Since Specialization
Citations

This map shows the geographic impact of Enisa Hasic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enisa Hasic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enisa Hasic more than expected).

Fields of papers citing papers by Enisa Hasic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enisa Hasic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enisa Hasic. The network helps show where Enisa Hasic may publish in the future.

Co-authorship network of co-authors of Enisa Hasic

This figure shows the co-authorship network connecting the top 25 collaborators of Enisa Hasic. A scholar is included among the top collaborators of Enisa Hasic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enisa Hasic. Enisa Hasic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
# Work Indexed citations
1 13
2 27
3 18
4
CD163+ and CD68+ cells in the adult human eye
3
5 40
6 21
7 144
8 158

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026